{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:16:18Z","timestamp":1762866978557,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T00:00:00Z","timestamp":1479686400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["PB-PG-0214-33069"],"award-info":[{"award-number":["PB-PG-0214-33069"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13063-016-1678-5","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T07:54:26Z","timestamp":1479714866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study"],"prefix":"10.1186","volume":"17","author":[{"given":"Inti","family":"Qurashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8921-4942","authenticated-orcid":false,"given":"Simon","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nusrat","family":"Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. F. W.","family":"Deakin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,21]]},"reference":[{"issue":"5","key":"1678_CR1","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1176\/appi.ps.51.5.666","volume":"51","author":"J Waserman","year":"2000","unstructured":"Waserman J, Criollo M. Subjective experiences of clozapine treatment by patients with chronic schizophrenia. Psychiatr Serv. 2000;51(5):666\u20138.","journal-title":"Psychiatr Serv"},{"issue":"2","key":"1678_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/schbul\/17.2.247","volume":"17","author":"A Safferman","year":"1991","unstructured":"Safferman A, Lieberman JA, Kane JM. Update on the clinical efficacy and side-effects of clozapine. Schizophr Bull. 1991;17(2):247\u201361.","journal-title":"Schizophr Bull"},{"issue":"3","key":"1678_CR3","first-page":"445","volume":"153","author":"ES Brodkin","year":"1996","unstructured":"Brodkin ES, Pelton GH, Price LH. Treatment of clozapine-induced parotid gland swelling. Am J Psychiatry. 1996;153(3):445.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"1678_CR4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/00004714-199612000-00013","volume":"16","author":"R Hinkes","year":"1996","unstructured":"Hinkes R, Quesada T, Currier MB. Aspiration pneumonia possibly secondary to clozapine-induced sialorrhea. J Clin Psychopharmacol. 1996;16(6):462\u20133.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"1678_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/2045125315581996","volume":"5","author":"I Qurashi","year":"2015","unstructured":"Qurashi I, Stephenson P, Chu S, Duffy C, Husain N, Chaudhry I. An evaluation of subjective experiences, effects and overall satisfaction with clozapine treatment in a UK forensic service. Ther Adv Psychopharmacol. 2015;5(3):146\u201350.","journal-title":"Ther Adv Psychopharmacol"},{"issue":"6","key":"1678_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/YIC.0b013e32834ab34c","volume":"26","author":"A Krivoy","year":"2011","unstructured":"Krivoy A, Malka L, Fischel T, Weizman A, Valevski A. Predictors of clozapine discontinuation in patients with schizophrenia. Int Clin Psychopharmacol. 2011;26(6):311\u201315.","journal-title":"Int Clin Psychopharmacol"},{"key":"1678_CR7","unstructured":"UK Medicines Information for NHS healthcare professionals. \u2018Q and A 54.4. Drug-induced hypersalivation \u2013 what treatment options are available?\u2019 \n                    www.awp.nhs.uk\/handlers\/downloads.ashx?id=6362\n                    \n                  . Accessed 17 Nov 2016."},{"issue":"3","key":"1678_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1037\/0735-7044.117.3.526","volume":"117","author":"SJ Sherman","year":"2003","unstructured":"Sherman SJ, Atri A, Hasselmo ME, Stern CE, Howard MW. Scopolamine impairs human recognition memory: data and modelling. Behav Neurosci. 2003;117(3):526\u201339.","journal-title":"Behav Neurosci"},{"issue":"6","key":"1678_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1177\/070674370705200607","volume":"52","author":"S Sockalingam","year":"2007","unstructured":"Sockalingam S, Shammi C, Remington G. Clozapine-induced hypersalivation: a review of treatment strategies. Can J Psychiatry. 2007;52(6):377\u201384.","journal-title":"Can J Psychiatry"},{"key":"1678_CR10","first-page":"CD005579","volume":"3","author":"R Syed","year":"2008","unstructured":"Syed R, Au K, Cahill C, Duggan L, He Y, Udu V, Xia J. Pharmacological interventions for clozapine-induced hypersalivation. Cochrane Database Syst Rev. 2008;3:CD005579.","journal-title":"Cochrane Database Syst Rev"},{"key":"1678_CR11","first-page":"3","volume":"1","author":"D Reddihough","year":"2011","unstructured":"Reddihough D, Reid S, Plover C. Evaluation of glycopyrrolate in the treatment of chronic drooling. Degener Neurol Neuromuscul Dis. 2011;1:3\u20137.","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"1678_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1365-2214.2011.01213.x","volume":"38","author":"JR Parr","year":"2012","unstructured":"Parr JR, Buswell CA, Banerjee KJ, Fairhurst C, Williams J, O\u2019Hare A. Management of drooling: a survey of UK clinicians\u2019 clinical practice. Child Care Health Dev. 2012;38:287\u201391.","journal-title":"Child Care Health Dev"},{"issue":"12","key":"1678_CR13","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1001\/archpedi.154.12.1214","volume":"154","author":"RJ Mier","year":"2000","unstructured":"Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M. Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med. 2000;154(12):1214\u20138.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1678_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/TCRM.S27362","volume":"8","author":"R Zeller","year":"2012","unstructured":"Zeller R, Davidson J, Lee H, Cavanaugh P. Safety and efficacy of glycopyrrolate oral solution for management of pathological drooling in paediatric patients with cerebral palsy and other neurological conditions. Ther Clin Risk Manage. 2012;8:25\u201332.","journal-title":"Ther Clin Risk Manage"},{"issue":"15","key":"1678_CR15","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1212\/WNL.0b013e3181d8c1b7","volume":"74","author":"ME Arbouw","year":"2010","unstructured":"Arbouw ME, Movig KL, Koopmann M, Poels PJ, Guchelaar HJ, Egberts TC, Nef C, van Vugt JP. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial. Neurology. 2010;74(15):1203\u20137.","journal-title":"Neurology"},{"issue":"1","key":"1678_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/cap.2007.0037","volume":"18","author":"AS Robb","year":"2008","unstructured":"Robb AS, Lee RH, Cooper EB, Siedel JV, Nusrat N. Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents. J Child Adolesc Psychopharmacol. 2008;18(1):99\u2013107.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1-3","key":"1678_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.schres.2010.02.1060","volume":"119","author":"CS Liang","year":"2010","unstructured":"Liang CS, Ho PS, Shen LJ, Lee WK, Yang FW, Chiang KT. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study. Schizophr Res. 2010;119(1-3):138\u201344.","journal-title":"Schizophr Res"},{"key":"1678_CR18","volume-title":"British National Formulary (62)","author":"British Medical Association and the Royal Pharmaceutical Society","year":"2011","unstructured":"British Medical Association and the Royal Pharmaceutical Society. British National Formulary (62). London: Pharmaceutical Press; 2011."},{"key":"1678_CR19","volume-title":"The Maudsley prescribing guidelines in psychiatry","author":"D Taylor","year":"2015","unstructured":"Taylor D, Paton C, Kapur S. The Maudsley prescribing guidelines in psychiatry. 12th ed. London: Wiley-Blackwell; 2015.","edition":"12"},{"issue":"2","key":"1678_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF02412423","volume":"3","author":"N Thomas-Stonell","year":"1988","unstructured":"Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia. 1988;3(2):73\u20138.","journal-title":"Dysphagia"},{"key":"1678_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2147\/NDT.S14028","volume":"7","author":"ML Evatt","year":"2011","unstructured":"Evatt ML. Oral glycopyrrolate for the treatment of chronic severe drooling caused by neurological disorders in children. Neuropsychiatr Dis Treat. 2011;7:543\u20137.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1678_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00004850-199707000-00005","volume":"12","author":"B Spivak","year":"1997","unstructured":"Spivak B, Adlersberg S, Rosen L, Gonen N, Mester R, Weizman A. Trihexyphenidyl treatment of clozapine-induced hypersalivation. Int Clin Psychopharmacol. 1997;12:213\u20135.","journal-title":"Int Clin Psychopharmacol"},{"key":"1678_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","volume":"68","author":"RSE Keefe","year":"2004","unstructured":"Keefe RSE, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004;68:283\u201397.","journal-title":"Schizophr Res"},{"key":"1678_CR24","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1192\/bjp.166.5.650","volume":"166","author":"JC Day","year":"1995","unstructured":"Day JC, Wood G, Dewey M, Bentall RP. A self-rating scale for measuring neuroleptic side-effects: Validation in a group of schizophrenic patients. Br J Psychiatry. 1995;166:650\u201353.","journal-title":"Br J Psychiatry"},{"issue":"5","key":"1678_CR25","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1752-8062.2011.00347.x","volume":"4","author":"CG Moore","year":"2011","unstructured":"Moore CG, Carter RE, Nietert PJ, Stewart PW. Recommendations for planning pilot studies in clinical and translational research. Clin Transl Sci. 2011;4(5):332\u20137.","journal-title":"Clin Transl Sci"},{"key":"1678_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/pst.185","volume":"4","author":"SA Julious","year":"2005","unstructured":"Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4:287\u201391.","journal-title":"Pharm Stat"},{"issue":"3","key":"1678_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0360-3016(80)90153-4","volume":"6","author":"D Schoenfeld","year":"1980","unstructured":"Schoenfeld D. Statistical considerations for pilot studies. Int J Radiat Oncol Biol Phys. 1980;6(3):371\u201374.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1678_CR28","volume-title":"Handbook for good clinical research practice (GCP): guidance for implementation","author":"World Health Organization","year":"2005","unstructured":"World Health Organization. Handbook for good clinical research practice (GCP): guidance for implementation. Geneva: WHO; 2005."},{"key":"1678_CR29","unstructured":"World Medical Association: Declaration of Helsinki. Ethical principles for medical research involving human subjects. \n                    www.wma.net\/en\/30publications\/10policies\/b3\/index.html\n                    \n                  . Accessed 17 Nov 2016."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1678-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-016-1678-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1678-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T05:44:56Z","timestamp":1487655896000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-016-1678-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,21]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1678"],"URL":"https:\/\/doi.org\/10.1186\/s13063-016-1678-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2016,11,21]]},"article-number":"553"}}